fashion -WSS

fashion

author：Wikipedia 2025-09-03 11:50:40 - browse：5

Mouse embryo in bottle. -- coverage from STAT — A mouse embryo model created entirely from stem cells. Scientists have since used similar systems to build models of human embryos. Jacob Hanna —Weizmann Institute

Earlier this month, a British journalist broke the news that researchers had taken a major step toward growing stem cells into structures that resemble human embryos.

Details about the experiments, and any sort of outside analysis of their quality or significance, were scarce, since the academic paper summarizing the work was still under peer review. But as the news spread around the globe, other scientists who had more quietly been working in the same area quickly posted preprints of their own progress.

Almost overnight, it seemed, the world was awash in different ways to coax stem cells into something that looked like the earliest days of a human life. The pushback was immediate, prompting accusations of overblown claims as well as outcry about ethical considerations and legal guardrails lagging behind the pace of scientific progress. Meanwhile, former Trump adviser Steve Bannon’s podcast, which studies have found to be a top spreader of misinformation, denounced synthetic babies as “the next abomination.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： What affirmative action's end means to a medical student

WSS

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

At JPM 2024, hospital systems pitch financial strength to investors

Profiling embryos to choose those with higher IQs is almost a reality

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Crowdfunding for unproven stem cell procedures spreads misinformation

leisure time

fashion

knowledge

In age of alternative facts, a scholarly course on calling out crap

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Hepatitis C has a cure — but many Americans still lack access to it

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Guidelines to prevent youth baseball injuries need more muscle

Dexcom's push to bring CGM to type 2 diabetes patients

In age of alternative facts, a scholarly course on calling out crap

AstraZeneca lung cancer study comes in below expectations

Duchenne breakthrough therapy leaves behind pioneering families

The biotech scorecard for Q3: 15 stock

explore

Dexcom's push to bring CGM to type 2 diabetes patients

The biotech scorecard for Q3: 15 stock

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Arena BioWorks launches in Cambridge to speed drug discovery

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Profiling embryos to choose those with higher IQs is almost a reality

knowledge

leisure time

hotspot

Wikipedia